(Nasdaq: ETWC), a provider of "eClinical" software and services for uses in clinical trials, moved into the black in the second quarter.
Boosted by an 11 percent growth in revenues to $4.2 million from a year ago, etrials posted a profit of $60,746. The company lost $101,627 in the same period in 2005.
The company now has 38 customers, up from 23 a year ago, and is working with 114 clinical trials. That's up from 102 in 2005.
"We are very pleased with our second quarter results and remain on track for a profitable year, before non-cash stock compensation expenses," said John Cline, chief executive officer of etrials.
Copyright 2024 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.